Ozempic and Mounjaro are FDA-approved diabetes drugs comprised of semaglutide, prescribed primarily for treatment of type 2 diabetes
These hormones help control hunger, slow stomach emptying, and improve blood sugar balance, making it easier to eat less without constant cravings or feelings of deprivation
Due to its prolonged half-life, the peptide has to be injected only once per week
In a cardiovascular outcomes trial of liraglutide 1.8 mg, weight loss was sustained over a median trial period of 3.5 years in patients with type 2 diabetes who had either cardiovascular disease or risk factors for cardiovascular disease [60]
To take liraglutide, you inject it under the skin of your thigh, abdomen, or upper arm on a daily basis